SCHEMBL3766697

SCHEMBL3766697

Cc1cccc(-c2nc(-c3cccc(C)c3)nc(-c3cccc(C)c3)n2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.73
NR1I3 Q14994 1/20 0.54
ACHE P22303 1/20 0.52
IDO1 P14902 1/20 0.52
METAP2 P50579 1/20 0.52
NPC1 O15118 7/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
TP53 P04637 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 1/20 0.50
CASP3 P42574 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
HRH4 Q9H3N8 1/20 0.49
TSHR P16473 2/20 0.49
MAPK1 P28482 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4546968 0.98 RAB9A (0.70) RAB9ANR1I3ACHEIDO1METAP2
SCHEMBL4546940 0.95 RAB9A (0.68) RAB9ANR1I3ACHEIDO1METAP2
SCHEMBL29712523 0.93 RAB9A (0.66) RAB9ANR1I3NPC1SMN1; SMN2TP53
SCHEMBL12264974 0.93 RAB9A (0.66) RAB9ANR1I3ACHEIDO1METAP2
SCHEMBL2883605 0.93 RAB9A (0.66) RAB9ANR1I3ACHEIDO1METAP2
SCHEMBL4546934 0.93 RAB9A (0.66) RAB9ANR1I3NPC1SMN1; SMN2TP53
SCHEMBL883671 0.93 RAB9A (0.66) RAB9ANR1I3NPC1SMN1; SMN2TP53
SCHEMBL4546932 0.91 RAB9A (0.63) RAB9ANR1I3IDO1METAP2NPC1
SCHEMBL17807600 0.91 RAB9A (0.63) RAB9ANR1I3IDO1METAP2NPC1
SCHEMBL2883804 0.89 RAB9A (0.61) RAB9ANR1I3NPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11796539-B2 Systems and methods for determining a characteristic of an emissive species C2Sense, Inc. (US) 2023-10-24 US disclosed
US-11796539-B2 Systems and methods for determining a characteristic of an emissive species C2Sense, Inc. (US) 2023-10-24 US disclosed
WO-2023178136-A2 STRETCHABLE LIGHT-EMITTING POLYMERS THE UNIVERSITY OF CHICAGO (US) 2023-09-21 WO disclosed
US-11726037-B2 Luminescence imaging for sensing and/or authentication C2Sense, Inc. (US) 2023-08-15 US disclosed
US-11726037-B2 Luminescence imaging for sensing and/or authentication C2Sense, Inc. (US) 2023-08-15 US disclosed
US-11662346-B2 Systems and methods for sensing using consumer electronic devices C2Sense, Inc. (US) 2023-05-30 US disclosed
US-11662346-B2 Systems and methods for sensing using consumer electronic devices C2Sense, Inc. (US) 2023-05-30 US disclosed
US-11656226-B2 Image generation for detection and related methods C2Sense, Inc. (US) 2023-05-23 US disclosed
US-11656226-B2 Image generation for detection and related methods C2Sense, Inc. (US) 2023-05-23 US disclosed
US-11513118-B2 Temporal thermal sensing and related methods C2Sense, Inc. (US) 2022-11-29 US disclosed
US-20130214263-A1 MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2013-08-22 US disclosed
US-8427046-B2 Monoamine compound, charge-transporting material, and organic electroluminescent device MITSUBISHI CHEMICAL CORPORATION (JP) 2013-04-23 US disclosed
US-8178215-B2 Organic compound containing at least two carbazolyl-substituted phenyl structures; charge-transporting material and organic el element containing the compound PIONEER CORPORATION (JP) 2012-05-15 US disclosed
US-20110108770-A1 COMPOSITION COMPRISING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-12 US disclosed
US-20110108770-A1 COMPOSITION COMPRISING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-12 US disclosed
US-7847888-B2 Liquid crystal display device including protective films having predetermined moisture permeability characteristics FUJIFILM CORPORATION (JP) 2010-12-07 US disclosed
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT PIONEER CORPORATION (JO) 2009-09-24 US disclosed
US-20090230846-A1 MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2009-09-17 US disclosed
US-20080218666-A1 Liquid crystal display device FUJIFILM CORPORATION (JP) 2008-09-11 US disclosed
US-3932402-A Preparation of sym-triazines by trimerization of nitriles in trifluoromethanesulfonic acid PHILLIPS PETROLEUM COMPANY (US) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090236973-A1 ORGANIC COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT ELEMENT SLCO4C1, SLCO2A1, SLCO2B1 RAB9A 1478/4885NR1I3 2288/4885ACHE 2219/4885
US-20090230846-A1 MONOAMINE COMPOUND, CHARGE-TRANSPORTING MATERIAL, AND ORGANIC ELECTROLUMINESCENT DEVICE SLC7A5, SLC18A1, MAOA RAB9A 362/4885NR1I3 2164/4885ACHE 778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.